MyChesCo on MSN19h
Traws Pharma Announces Virtual Investor Event to Showcase Innovative Treatments for Bird Flu and COVID-19
NEWTON, PA — Traws Pharma, Inc. (NASDAQ: TRAW) is set to host a virtual investor event on Monday, March 31, 2025, at 10:00 AM ...
Artificial cells can glow at room temperature in response to external target molecules
Cell-free systems, which can express an easily detectable protein with a DNA or mRNA template without constraints of living ...
Dewpoint Therapeutics announces upcoming presentations at AACR 2025
Dewpoint will present two posters at AACRCondensate modulators (c-mods) demonstrate robust anti-tumor effects across multiple ...
Avacta Therapeutics Announces Presentations at 2025 AACR Annual Meeting
Avacta Therapeutics (AIM: AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting ...
T-knife Therapeutics Announces Five Presentations at American Association for Cancer Research (AACR) Annual Meeting
Multiple presentations demonstrate that T-knife’s proprietary next-generation technologies address important challenges with current cell therapy ...
Nurix Therapeutics Announces Multiple Presentations at the American Association for Cancer Research (AACR) 2025 Annual Meeting
About NRX-0305 NRX-0305 is a potent, selective, and orally bioavailable mutant-specific BRAF degrader that Nurix is exploring for use in oncology. Nurix has reported preclinical data demonstrating ...